MicroRNA-302b-inhibited E2F3 transcription factor is related to all trans retinoic acid-induced glioma cell apoptosis

Journal of Neurochemistry

Volumn 131, Issue 6, 2014, Pages 731-742

  Chen, Peng Hsu ^a   Shih, Chwen Ming ^a,b   Chang, Wei Chiao ^c   Cheng, Chia Hsiung ^a,b   Lin, Cheng Wei ^a,b   Ho, Kuo Hao ^c   Su, Po Chia ^c   Chen, Ku Chung ^a,b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

all trans retinoic acid; apoptosis; E2F3; glioblastoma; miR 302b

Indexed keywords

MICRORNA; MICRORNA 302B; REACTIVE OXYGEN METABOLITE; RETINOIC ACID; TRANSCRIPTION FACTOR E2F3; UNCLASSIFIED DRUG; MIRN302 MICRORNA, HUMAN; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR ALPHA;

APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOSE RESPONSE; ENDOPLASMIC RETICULUM STRESS; FLOW CYTOMETRY; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; GLIOMA CELL; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MITOCHONDRIAL MEMBRANE POTENTIAL; NUCLEOTIDE SEQUENCE; UPREGULATION; CELL DIFFERENTIATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GLIOMA; METABOLISM; TUMOR CELL LINE;

APOPTOSIS; CELL DIFFERENTIATION; CELL LINE, TUMOR; E2F3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; GLIOMA; HUMANS; MICRORNAS; REACTIVE OXYGEN SPECIES; RECEPTORS, RETINOIC ACID; TRETINOIN;

EID: 84918782784     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12820     Document Type: Article

References (44)

1. Auffinger B., Thaci B., Ahmed A., Ulasov I., and, Lesniak M. S., (2013) MicroRNA targeting as a therapeutic strategy against glioma. Curr. Mol. Med. 13, 535-542.
2. Barroso-del Jesus A., Lucena-Aguilar G., and, Menendez P., (2009) The miR-302-367 cluster as a potential stemness regulator in ESCs. Cell Cycle 8, 394-398.
3. Brautigam C., Raggioli A., and, Winter J., (2013) The Wnt/beta-catenin pathway regulates the expression of the miR-302 cluster in mouse ESCs and P19 cells. PLoS ONE 8, e75315.
4. Brtko J., (2007) Role of retinoids and their cognate nuclear receptors in breast cancer chemoprevention. Cent. Eur. J. Public Health 15, 3-6.
5. Cai N., Wang Y. D., and, Zheng P. S., (2013) The microRNA-302-367 cluster suppresses the proliferation of cervical carcinoma cells through the novel target AKT1. RNA 19, 85-95.
6. Cui J. G., Zhao Y., Sethi P., Li Y. Y., Mahta A., Culicchia F., and, Lukiw W. J., (2010) Micro-RNA-128 (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferation. J. Neurooncol. 98, 297-304.
7. Das A., Banik N. L., and, Ray S. K., (2009) Molecular mechanisms of the combination of retinoid and interferon-gamma for inducing differentiation and increasing apoptosis in human glioblastoma T98G and U87MG cells. Neurochem. Res. 34, 87-101.
8. Das S., Foley N., Bryan K., Watters K. M., Bray I., Murphy D. M., Buckley P. G., and, Stallings R. L., (2010) MicroRNA mediates DNA demethylation events triggered by retinoic acid during neuroblastoma cell differentiation. Cancer Res. 70, 7874-7881.
9. Das S., Bryan K., Buckley P. G., et al,. (2013) Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs. Oncogene 32, 2927-2936.
10. Fareh M., Turchi L., Virolle V., et al,. (2012) The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network. Cell Death Differ. 19, 232-244.
11. Foley N. H., Bray I., Watters K. M., Das S., Bryan K., Bernas T., Prehn J. H., and, Stallings R. L., (2011) MicroRNAs 10a and 10b are potent inducers of neuroblastoma cell differentiation through targeting of nuclear receptor corepressor 2. Cell Death Differ. 18, 1089-1098.
12. Friedman H. S., Kerby T., and, Calvert H., (2000) Temozolomide and treatment of malignant glioma. Clin. Cancer Res. 6, 2585-2597.
13. Gao S. M., Yang J., Chen C., Zhang S., Xing C. Y., Li H., Wu J., and, Jiang L., (2011) miR-15a/16-1 enhances retinoic acid-mediated differentiation of leukemic cells and is up-regulated by retinoic acid. Leuk. Lymphoma 52, 2365-2371.
14. Garzon R., Pichiorri F., Palumbo T., et al,. (2007) MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene 26, 4148-4157.
15. Gunther W., Pawlak E., Damasceno R., Arnold H., and, Terzis A. J., (2003) Temozolomide induces apoptosis and senescence in glioma cells cultured as multicellular spheroids. Br. J. Cancer 88, 463-469.
16. Haque A., Banik N. L., and, Ray S. K., (2007a) Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma. Neurochem. Res. 32, 2203-2209.
17. Haque A., Das A., Hajiaghamohseni L. M., Younger A., Banik N. L., and, Ray S. K., (2007b) Induction of apoptosis and immune response by all-trans retinoic acid plus interferon-gamma in human malignant glioblastoma T98G and U87MG cells. Cancer Immunol. Immunother. 56, 615-625.
18. Jian P., Li Z. W., Fang T. Y., Jian W., Zhuan Z., Mei L. X., Yan W. S., and, Jian N., (2011) Retinoic acid induces HL-60 cell differentiation via the upregulation of miR-663. J. Hematol. Oncol. 4, 20.
19. Karmakar S., Banik N. L., Patel S. J., and, Ray S. K., (2007) Combination of all-trans retinoic acid and taxol regressed glioblastoma T98G xenografts in nude mice. Apoptosis 12, 2077-2087.
20. Karmakar S., Banik N. L., and, Ray S. K., (2008) Combination of all-trans retinoic acid and paclitaxel-induced differentiation and apoptosis in human glioblastoma U87MG xenografts in nude mice. Cancer 112, 596-607.
21. Karsy M., Arslan E., and, Moy F., (2012) Current progress on understanding MicroRNAs in glioblastoma multiforme. Genes Cancer 3, 3-15.
22. Kast R. E., (2008) Potential for all-trans retinoic acid (tretinoin) to enhance interferon-alpha treatment response in chronic myelogenous leukemia, melanoma, myeloma and renal cell carcinoma. Cancer Biol. Ther. 7, 1515-1519.
23. Khalili M., Sadeghizadeh M., Ghorbanian K., Malekzadeh R., Vasei M., and, Mowla S. J., (2012) Down-regulation of miR-302b, an ESC-specific microRNA, in Gastric Adenocarcinoma. Cell J. 13, 251-258.
24. Le M. T., Xie H., Zhou B., et al,. (2009) MicroRNA-125b promotes neuronal differentiation in human cells by repressing multiple targets. Mol. Cell. Biol. 29, 5290-5305.
25. Lewis B. P., Burge C. B., and, Bartel D. P., (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20.
26. Lin S. L., Chang D. C., Ying S. Y., Leu D., and, Wu D. T., (2010) MicroRNA miR-302 inhibits the tumorigenecity of human pluripotent stem cells by coordinate suppression of the CDK2 and CDK4/6 cell cycle pathways. Cancer Res. 70, 9473-9482.
27. Lin C. J., Lee C. C., Shih Y. L., Lin T. Y., Wang S. H., Lin Y. F., and, Shih C. M., (2012) Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy. Free Radic. Biol. Med. 52, 377-391.
28. Pelosi A., Careccia S., Lulli V., et al,. (2013) miRNA let-7c promotes granulocytic differentiation in acute myeloid leukemia. Oncogene 32, 3648-3654.
29. Schmidt-Mende J., Gogvadze V., Hellstrom-Lindberg E., and, Zhivotovsky B., (2006) Early mitochondrial alterations in ATRA-induced cell death. Cell Death Differ. 13, 119-128.
30. Serao N. V., Delfino K. R., Southey B. R., Beever J. E., and, Rodriguez-Zas S. L., (2011) Cell cycle and aging, morphogenesis, and response to stimuli genes are individualized biomarkers of glioblastoma progression and survival. BMC Med. Genomics 4, 49.
31. Shi L., Chen J., Yang J., Pan T., Zhang S., and, Wang Z., (2010) MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity. Brain Res. 1352, 255-264.
32. Tucci P., Cione E., Perri M., and, Genchi G., (2008) All-trans-retinoic acid induces apoptosis in Leydig cells via activation of the mitochondrial death pathway and antioxidant enzyme regulation. J. Bioenerg. Biomembr. 40, 315-323.
33. Wang L., Yao J., Shi X., Hu L., Li Z., Song T., and, Huang C., (2013a) MicroRNA-302b suppresses cell proliferation by targeting EGFR in human hepatocellular carcinoma SMMC-7721 cells. BMC Cancer 13, 448.
34. Wang L., Yao J., Zhang X., et al,. (2013b) miRNA-302b Suppresses Human Hepatocellular Carcinoma by Targeting AKT2. Mol. Cancer Res., 12, 190-202.
35. Wang C. Y., Yang T. T., Chen C. L., Lin W. C., and, Lin C. F., (2014) Reactive oxygen species-regulated glycogen synthase kinase-3beta activation contributes to all-trans retinoic acid-induced apoptosis in granulocyte-differentiated HL60 cells. Biochem. Pharmacol., 88, 86-94.
36. Welch C., Chen Y., and, Stallings R. L., (2007) MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 26, 5017-5022.
37. Xu Y. Y., Lu Y., Fan K. Y., and, Shen Z. H., (2007) Apoptosis induced by all-trans retinoic acid in N-acetylglucosaminyltransferase V repressed human hepatocarcinoma cells is mediated through endoplasmic reticulum stress. J. Cell. Biochem. 100, 773-782.
38. Yan G. J., Yu F., Wang B., Zhou H. J., Ge Q. Y., Su J., Hu Y. L., Sun H. X., and, Ding L. J., (2013) MicroRNA miR-302 inhibits the tumorigenicity of endometrial cancer cells by suppression of Cyclin D1 and CDK1. Cancer Lett., 345, 39-47.
39. Yan G. J., Yu F., Wang B., Zhou H. J., Ge Q. Y., Su J., Hu Y. L., Sun H. X., and, Ding L. J., (2014) MicroRNA miR-302 inhibits the tumorigenicity of endometrial cancer cells by suppression of Cyclin D1 and CDK1. Cancer Lett. 345, 39-47.
40. Zhang H., Satyamoorthy K., Herlyn M., and, Rosdahl I., (2003) All-trans retinoic acid (atRA) differentially induces apoptosis in matched primary and metastatic melanoma cells-a speculation on damage effect of atRA via mitochondrial dysfunction and cell cycle redistribution. Carcinogenesis 24, 185-191.
41. Zhang Y., Chao T., Li R., et al,. (2009) MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a. J. Mol. Med. (Berl) 87, 43-51.
42. Zhang Q. Q., Xu H., Huang M. B., Ma L. M., Huang Q. J., Yao Q., Zhou H., and, Qu L. H., (2012) MicroRNA-195 plays a tumor-suppressor role in human glioblastoma cells by targeting signaling pathways involved in cellular proliferation and invasion. Neuro Oncol. 14, 278-287.
43. Zhang Y., Hu H., Song L., Cai L., Wei R., and, Jin W., (2013) Epirubicin-mediated expression of miR-302b is involved in osteosarcoma apoptosis and cell cycle regulation. Toxicol. Lett. 222, 1-9.
44. Zhu R., Yang Y., Tian Y., et al,. (2012) Ascl2 knockdown results in tumor growth arrest by miRNA-302b-related inhibition of colon cancer progenitor cells. PLoS ONE 7, e32170.